Cargando…
Enhanced production of taxadiene in Saccharomyces cerevisiae
BACKGROUND: Cost-effective production of the highly effective anti-cancer drug, paclitaxel (Taxol(®)), remains limited despite growing global demands. Low yields of the critical taxadiene precursor remains a key bottleneck in microbial production. In this study, the key challenge of poor taxadiene s...
Autores principales: | Nowrouzi, Behnaz, Li, Rachel A., Walls, Laura E., d’Espaux, Leo, Malcı, Koray, Liang, Lungang, Jonguitud-Borrego, Nestor, Lerma-Escalera, Albert I., Morones-Ramirez, Jose R., Keasling, Jay D., Rios-Solis, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607689/ https://www.ncbi.nlm.nih.gov/pubmed/33138820 http://dx.doi.org/10.1186/s12934-020-01458-2 |
Ejemplares similares
-
Exploring optimal Taxol® CYP725A4 activity in Saccharomyces cerevisiae
por: Nowrouzi, Behnaz, et al.
Publicado: (2022) -
Improved production of Taxol(®) precursors in S. cerevisiae using combinatorial in silico design and metabolic engineering
por: Malcı, Koray, et al.
Publicado: (2023) -
High—throughput and automated screening for COVID-19
por: Jonguitud-Borrego, Nestor, et al.
Publicado: (2022) -
Elimination of enzymes catalysis compartmentalization enhancing taxadiene production in Saccharomyces cerevisiae
por: Zhang, Chenglong, et al.
Publicado: (2023) -
A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae
por: Reider Apel, Amanda, et al.
Publicado: (2017)